Article

New mindset suggested for prescribing beta-blockers

Since the release of the topical beta-blocker timolol maleate (Timoptic, Merck) some 2 decades ago, glaucoma patients have been the beneficiaries of a cascade of new IOP-lowering pharmaceuticals.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
© 2025 MJH Life Sciences

All rights reserved.